PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease Reportspituitary acth hypersecretion
MeSH D047748 - pituitary acth hypersecretion
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D006964:Hyperpituitarism
0 Companies
0 Drugs
Success rate
D047748: 
Pituitary acth hypersecretion
1 Company
1 Drug
$
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
RecordatiPasireotide Signifor  2012-04-24   
Clinical Trials
Historical Success Rate
Phase 1
25%
1/4
Phase 2
36%
5/14
Phase 3
38%
3/8
Approved: 1Overall Success rate: 3%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Recordati
Pasireotide,
PASIREOTIDE DIASPARTATE,
Aglatimagene besadenovec,
Ademetionine,
Somatostatin,
Aspartame,
Intermedine
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use